How Hollar was paid
$22.6M in total for fiscal 2026, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Incentive | Other | Total |
|---|---|---|---|---|---|
| Jason M. HollarChief Executive Officer | $1,500,000 | $16,259,918 | $4,278,750 | $535,681 | $22,574,349 |
| Aaron E. AltChief Financial Officer | $896,233 | $4,318,999 | $1,606,945 | $37,996 | $6,860,173 |
| Stephen M. MasonChief Executive Officer, Global Medical Products and Distribution Segment | $761,986 | $3,404,479 | $1,112,500 | $14,400 | $5,293,365 |
| Deborah L. WeitzmanChief Executive Officer, Pharmaceutical and Specialty Solutions Segment | $770,479 | $4,064,943 | $1,254,340 | $30,395 | $6,120,157 |
| Jessica L. MayerChief Legal and Compliance Officer | $741,233 | $3,556,822 | $1,208,210 | $27,918 | $5,534,183 |
What changed and why
- 22,574,349 CEO total compensation increased from 18,976,195 in fiscal 2025.
- 16,259,918 in CEO stock awards comprised the largest component of fiscal 2026 compensation.
- 60%60% of annual incentive payout depended on adjusted operating earnings or adjusted segment profit.
- 70%70% of fiscal 2026 PSU payout depended on adjusted EPS CAGR plus average annual dividend yield.
- 480,137 of CEO all-other compensation reflected personal corporate aircraft use.
- 91%91% of votes cast supported the 2025 say-on-pay proposal.
Other Cardinal Health proxy statements
- 2025 proxy statement
Jason M. Hollar paid $19M (-26% on the year), pay ratio 261:1.
Filed Sep 16, 2025
About this page
The figures were read out of the DEF 14A proxy statement on EDGAR by a language model and every number was then checked against the filing text; a figure that could not be found there is left out rather than shown. Totals follow SEC rules, which value stock and option awards at grant. Read the filing for footnotes and the compensation committee's full reasoning.